Gerresheimer plunges after it pospones results, warns of accounting probe

Gerresheimer AG

11/02/2026 07:53

** Shares in Gerresheimer GXIG.DE are down 19% in early Frankfurt trading after the German medical equipment maker said it expects a wider probe into its accounting practices to impact its 2025 results

** Since Germany's financial regulator, BaFin, first announced last September a review of the company's financial statements as of November 30, 2024, Gerresheimer has parted with its former CEO

** The company said it decided to delay the release of its results, originally due February 26, citing the probe

** Adjusted 2025 earnings per share are now expected to decrease in the high-double-digit percentage range and may turn negative

** The company cut its 2025 EBITA margin outlook to between 16.5% and 17.5%, from an earlier range of 18.5% to 19.0%

** "Story now gets really ugly. Shares tried to bottom out –this will probably fail today," said a local trader

** Until yesterday's close, the stock has fallen 1.38% year-to-date after dropping around 60% in 2025

 (Reporting by Maria Rugamer)

 ((Maria.Rugamer@thomsonreuters.com))